Across a county in Texas, geographic patterning of census tract-level rates of COPD-related ED visits and hospitalizations ...

People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.

Phase 3 studies report meaningful reductions in exacerbations across broad patient groups Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved ...

COPD without smoking? New data reveal unexpected symptoms and inflammation patterns. Read more to see what this means for ...

Tozorakimab is an investigational monoclonal antibody designed to bind and inhibit interleukin-33 (IL-33), an alarmin cytokine. This targeted approach is expected to reduce airway inflammation and ...

The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...

Positive data from the MIRANDA trial follows the OBERON and TITANIA studies of tozorakimab in COPD.

This is read by an automated voice. Please report any issues or inconsistencies here. The number of typhus infections from fleas has hit a record high in L.A. County. Public health professionals say ...

Cases of invasive meningococcal disease, a dangerous bacterial infection, have reached their highest level in a decade, according to data compiled by CBC News, after hitting a record low during the ...

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically ...

Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...

Annual cases of invasive meningococcal disease (IMD), a rare but dangerous bacterial infection, have hit the highest level seen in Canada in more than a decade. This rapidly progressing illness is ...